[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3,4,5,6,9,11,13,14,14a,14b-decahydro-3,6-dihydroxy-3-(hydroxymethyl)-4,5,6-trimethyl-,(3S,4R,5R,6R,14aR,14bR)- (9CI)
| Product Information | |
|---|---|
| Product Number: | AX-M7K9 |
| Product Name: | [1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3,4,5,6,9,11,13,14,14a,14b-decahydro-3,6-dihydroxy-3-(hydroxymethyl)-4,5,6-trimethyl-,(3S,4R,5R,6R,14aR,14bR)- (9CI) |
| CAS: | 6190-25-6 |
| MW: | 0 |
| Synonyms: | 21-Norsenecionan-11,16-dione,15,20-dihydro-12,15,20-trihydroxy-14-methyl-, (14a,15a)-; Sceleratine (6CI,7CI,8CI); Sceleratin;[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3,4,5,6,9,11,13,14,14a,14b-decahydro-3,6-dihydroxy-3-(hydroxymethyl)-4,5,6-trimethyl-,[3S-(3R*,4S*,5S*,6S*,14aS*,14bS*)]- |
| EINECS: | |
| Density: | |
| Melting Point: | |
| Boiling Point: | |
| Flash Point: | |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |